Neuropsychiatric Disease and Treatment
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.2 | Q2 | 65.5% | 0.947 | Q2 | 82.4% |
| 2024 | 2.9 | Q2 | 66.0% | 0.913 | Q2 | 81.8% |
| 2023 | 2.5 | Q2 | 56.7% | 0.849 | Q2 | 81.5% |
| 2022 | 3.2 | Q2 | 61.0% | 0.789 | Q2 | 80.1% |
| 2021 | 3.0 | Q3 | 53.1% | 0.774 | Q2 | 80.2% |
| 2020 | — | — | 0.819 | Q2 | 80.4% | |
| 2019 | — | — | 0.863 | Q2 | 82.2% | |
| 2018 | — | — | 0.897 | Q2 | 81.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1178-2021
country
GBcoverage
2001, 2006-2026